Clinical Trial Update: A Proof of Concept Pilot Study of the Addition of Venetoclax to Standard Remission Induction Chemotherapy Fludarabine or Cladrabine, Cytarabine, and Granulocyte Colony Stimulating Factor (G-CSF) (FLAG or CLAG) for Frontline Therapy of Secondary Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adding venetoclax to FLAG/CLAG induction therapy for frontline treatment of secondary acute myeloid leukemia; the study is currently su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Secondary Acute Myeloid Leukemia | Phase 2 | Status: SUSPENDED